Meet Ultima Genomics at the Cancer Genomics Consortium 2026
We are enthusiastic to discuss how our whole-genome sequencing method, ppmSeq™ for minimal residual disease (MRD) detection is redefining what’s possible in cancer genomics. From accelerating large‑scale studies to enabling earlier, more precise detection of recurrence, Ultima is delivering the power, speed, and resolution researchers need to unlock the next breakthroughs in cancer science.
Meet with us at CGC 2026
Request a meeting